Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 4
1949 5
1951 3
1952 5
1953 2
1954 5
1955 6
1956 5
1957 2
1958 8
1959 2
1961 9
1962 15
1963 16
1964 15
1965 18
1966 22
1967 31
1968 26
1969 39
1970 33
1971 21
1972 26
1973 24
1974 34
1975 33
1976 21
1977 21
1978 33
1979 38
1980 49
1981 53
1982 71
1983 79
1984 95
1985 104
1986 107
1987 111
1988 127
1989 139
1990 151
1991 150
1992 130
1993 124
1994 108
1995 142
1996 151
1997 168
1998 191
1999 204
2000 238
2001 205
2002 257
2003 272
2004 311
2005 324
2006 368
2007 386
2008 357
2009 398
2010 387
2011 448
2012 516
2013 512
2014 522
2015 552
2016 564
2017 619
2018 635
2019 628
2020 774
2021 960
2022 823
2023 845
2024 782
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,150 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: sato y. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Free PMC article. Clinical Trial.
RASopathies for Radiologists.
Handa A, Tsujioka Y, Nishimura G, Nozaki T, Kono T, Jinzaki M, Harms T, Connolly SA, Sato TS, Sato Y. Handa A, et al. Among authors: sato y. Radiographics. 2024 May;44(5):e230153. doi: 10.1148/rg.230153. Radiographics. 2024. PMID: 38602868
CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury.
Sato Y, Oguchi A, Fukushima Y, Masuda K, Toriu N, Taniguchi K, Yoshikawa T, Cui X, Kondo M, Hosoi T, Komidori S, Shimizu Y, Fujita H, Jiang L, Kong Y, Yamanashi T, Seita J, Yamamoto T, Toyokuni S, Hamazaki Y, Hattori M, Yoshikai Y, Boor P, Floege J, Kawamoto H, Murakawa Y, Minato N, Yanagita M. Sato Y, et al. J Clin Invest. 2022 Jan 18;132(2):e146071. doi: 10.1172/JCI146071. J Clin Invest. 2022. PMID: 34813503 Free PMC article.
CD163+ Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma.
Mori M, Sakamoto A, Kawakami R, Guo L, Slenders L, Mosquera JV, Ghosh SKB, Wesseling M, Shiraki T, Bellissard A, Shah P, Weinkauf CC, Konishi T, Sato Y, Cornelissen A, Kawai K, Jinnouchi H, Xu W, Vozenilek AE, Williams D, Tanaka T, Sekimoto T, Kelly MC, Fernandez R, Grogan A, Coslet AJ, Fedotova A, Kurse A, Mokry M, Romero ME, Kolodgie FD, Pasterkamp G, Miller CL, Virmani R, Finn AV. Mori M, et al. Among authors: sato y. Circ Res. 2024 Jul 5;135(2):e4-e23. doi: 10.1161/CIRCRESAHA.123.324082. Epub 2024 Jun 11. Circ Res. 2024. PMID: 38860377
Immune checkpoints in autoimmune vasculitis.
Sato Y, Tada M, Goronzy JJ, Weyand CM. Sato Y, et al. Best Pract Res Clin Rheumatol. 2024 May;38(2):101943. doi: 10.1016/j.berh.2024.101943. Epub 2024 Apr 9. Best Pract Res Clin Rheumatol. 2024. PMID: 38599937 Review.
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT).
Sakata Y, Sakata S, Oya Y, Tamiya M, Suzuki H, Shibaki R, Okada A, Kobe H, Matsumoto H, Yokoi T, Sato Y, Uenami T, Saito G, Tsukita Y, Inaba M, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Morinaga J, Sakagami T. Sakata Y, et al. Among authors: sato y. Eur J Cancer. 2021 Dec;159:144-153. doi: 10.1016/j.ejca.2021.09.041. Epub 2021 Nov 5. Eur J Cancer. 2021. PMID: 34749119
Histamine Neuroimaging in Stress-Related Disorders.
Fukudo S, Kano M, Sato Y, Muratsubaki T, Kanazawa M, Tashiro M, Yanai K. Fukudo S, et al. Among authors: sato y. Curr Top Behav Neurosci. 2022;59:113-129. doi: 10.1007/7854_2021_262. Curr Top Behav Neurosci. 2022. PMID: 35156186 Review.
14,150 results
You have reached the last available page of results. Please see the User Guide for more information.